These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2962335)
1. Reproducibility of platelet survival time measurements in patients with peripheral arterial occlusive disease. Minar E; Ehringer H Thromb Res; 1987 Oct; 48(1):73-9. PubMed ID: 2962335 [TBL] [Abstract][Full Text] [Related]
2. Influence of acetylsalicylic acid (1.0 g/day) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. Minar E; Ehringer H Thromb Res; 1987 Mar; 45(6):791-802. PubMed ID: 2954264 [TBL] [Abstract][Full Text] [Related]
3. Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. Minar E; Ehringer H; Jung M; Koppensteiner R; Stümpflen A Thromb Res; 1988 Nov; 52(3):219-26. PubMed ID: 2973666 [TBL] [Abstract][Full Text] [Related]
4. Lack of elevation of beta-thromboglobulin and platelet factor 4 in plasma during exercise in patients with chronic peripheral arterial occlusive disease. Minar E; Ehringer H; Schöfl R Klin Wochenschr; 1987 May; 65(9):419-23. PubMed ID: 2955158 [TBL] [Abstract][Full Text] [Related]
5. [Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease]. Minar E; Ehringer H; Jung M; Koppensteiner R; Stümpflen A; Ahmadi R Vasa Suppl; 1989; 27():244-6. PubMed ID: 2533741 [No Abstract] [Full Text] [Related]
6. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease. Galt SW; McDaniel MD; Ault KA; Mitchell J; Cronenwett JL J Vasc Surg; 1991 Dec; 14(6):747-55; discussion 755-6. PubMed ID: 1720468 [TBL] [Abstract][Full Text] [Related]
7. Platelet factor 4 and beta thromboglobulin in Moya-Moya disease. Albala MM; Levine PH Am J Pediatr Hematol Oncol; 1984; 6(1):96-9. PubMed ID: 6201080 [TBL] [Abstract][Full Text] [Related]
8. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension. Gomi T; Ikeda T; Yuhara M; Sakurai J; Nakayama D; Ikegami F J Hypertens; 1988 May; 6(5):389-92. PubMed ID: 2968397 [TBL] [Abstract][Full Text] [Related]
9. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome. Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902 [TBL] [Abstract][Full Text] [Related]
10. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. Zahavi J; Zahavi M Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092 [TBL] [Abstract][Full Text] [Related]
11. Platelet function in diabetic retinopathy: levels of beta-thromboglobulin and platelet factor 4. Fenández-Vigo J; Cordido M; Fernández Sabugal J; Cordido F Metab Pediatr Syst Ophthalmol (1985); 1992; 15(1-3):5-8. PubMed ID: 1484500 [TBL] [Abstract][Full Text] [Related]
12. Abnormal typical pattern of platelet function and thromboxane generation in unstable angina. Zahavi M; Zahavi J; Schafer R; Firsteter E; Laniado S Thromb Haemost; 1989 Nov; 62(3):840-5. PubMed ID: 2531938 [TBL] [Abstract][Full Text] [Related]
13. Platelet deposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries: investigations with indium-111-oxine labelled platelets in patients with ASA (1.0 g/day)-therapy. Minar E; Ehringer H; Ahmadi R; Dudczak R; Porenta G Thromb Haemost; 1987 Aug; 58(2):718-23. PubMed ID: 2960029 [TBL] [Abstract][Full Text] [Related]
14. Platelet activation in angina at rest. Evidence by paired measurement of plasma beta-thromboglobulin and platelet factor 4. De Caterina R; Gazzetti P; Mazzone A; Marzilli M; L'Abbate A Eur Heart J; 1988 Aug; 9(8):913-22. PubMed ID: 2972544 [TBL] [Abstract][Full Text] [Related]
15. Platelet tests and antiplatelet drugs in coronary artery disease. de Boer AC; Han P; Turpie AG; Butt R; Gent M; Genton E Circulation; 1983 Mar; 67(3):500-4. PubMed ID: 6217921 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG]. Ferri GM; Afeltra A; Caccavo D; Amoroso A Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709 [No Abstract] [Full Text] [Related]
17. A study of beta-thromboglobulin and platelet factor-4 plasma levels in steady state sickle cell patients. Adamides S; Konstantopoulos K; Toumbis M; Douratsos D; Travlou A; Kasfiki A Blut; 1990 Oct; 61(4):245-7. PubMed ID: 2145991 [TBL] [Abstract][Full Text] [Related]
18. Plasma levels of beta-thromboglobulin and platelet factor 4 in relation to the venous platelet concentration. Kutti J; Safai-Kutti S; Zaroulis CG; Good RA Acta Haematol; 1980; 64(1):1-5. PubMed ID: 6158243 [TBL] [Abstract][Full Text] [Related]
19. [Platelets and migraine. Correlation between biochemical markers of platelet aggregation and serotonin]. Leira R; Castillo J; Martínez F; Castro A; Lema M; Noya M Neurologia; 1991 Jan; 6(1):10-2. PubMed ID: 1830748 [TBL] [Abstract][Full Text] [Related]
20. Platelet activation during treadmill exercise in patients with chronic peripheral arterial disease. Baele G; Bogaerts H; Clement DL; Pannier R; Barbier F Thromb Res; 1981 Aug; 23(3):215-23. PubMed ID: 6458119 [No Abstract] [Full Text] [Related] [Next] [New Search]